Literature DB >> 30859186

Phosphorylation of PDE4A5 by MAPKAPK2 attenuates fibrin degradation via p75 signalling.

K F Houslay1, B A Fertig2, F Christian2, A J Tibbo2, J Ling2, J E Findlay3, M D Houslay3, G S Baillie2.   

Abstract

Phosphodiesterases (PDEs) shape local cAMP gradients to underpin the specificity of receptor function. Key to this process is the highly defined nature of the intra-cellular location of PDEs in the cell. PDE4A5 is a PDE isoform that specifically degrades cAMP and is known to associate with the p75 neurotrophin receptor (p75NTR) where it modulates cAMP signalling cascades that regulate extracellular matrix remodelling in the lungs. Here we map and validate novel protein-protein interaction sites that are important for formation of the PDE4A5-p75NTR complex and show, for the first time, that phosphorylation of PDE4A5 by MAPKAPK2 enhances PDE4A5 interaction with p75NTR and that this, in turn, serves to attenuate fibrin degradation.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Japanese Biochemical Society.

Entities:  

Keywords:  PDE4A; cyclic-AMP; extracellular matrix; p75-NTR; phosphodiesterase

Mesh:

Substances:

Year:  2019        PMID: 30859186      PMCID: PMC6607969          DOI: 10.1093/jb/mvz016

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.241


This article has been retracted. Please see: https://doi.org/10.1093/jb/mvac074
  5 in total

Review 1.  Phosphodiesterase isoforms and cAMP compartments in the development of new therapies for obstructive pulmonary diseases.

Authors:  Martina Schmidt; Isabella Cattani-Cavalieri; Francisco J Nuñez; Rennolds S Ostrom
Journal:  Curr Opin Pharmacol       Date:  2020-07-01       Impact factor: 5.547

2.  Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer.

Authors:  Deri Morgan; Kiersten L Berggren; Colby D Spiess; Hannah M Smith; Ajay Tejwani; Scott J Weir; Christopher E Lominska; Sufi M Thomas; Gregory N Gan
Journal:  Mol Carcinog       Date:  2021-09-24       Impact factor: 4.784

3.  Fibrin Breakdown Assay.

Authors:  Jiayue Ling; Connor M Blair; George S Baillie
Journal:  Bio Protoc       Date:  2020-04-20

4.  Measuring cAMP Specific Phosphodiesterase Activity: A Two-step Radioassay.

Authors:  Connor M Blair; Jiayue Ling; George S Baillie
Journal:  Bio Protoc       Date:  2020-04-05

5.  Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1.

Authors:  Haoming Chen; Ravi Padia; Tao Li; Yue Li; Bin Li; Lingtao Jin; Shuang Huang
Journal:  NPJ Breast Cancer       Date:  2021-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.